5-Bromo-7-Azaindole in PARP Inhibitor Synthesis: Slurry Reactivity & Moisture Control
Moisture Control (<0.2%) in 5-Bromo-7-azaindole: Preventing Boronic Acid Hydrolysis in Suzuki-Miyaura Coupling
In the synthesis of PARP inhibitors, the Suzuki-Miyaura coupling of 5-bromo-7-azaindole with boronic acids is a critical step. However, the presence of moisture above 0.2% can lead to significant boronic acid hydrolysis, reducing yield and generating impurities that are difficult to purge. As a heterocyclic building block, 5-bromo-7-azaindole (CAS 183208-35-7) is hygroscopic, and its handling demands rigorous moisture control. From our field experience, even brief exposure to ambient air during weighing can push moisture levels beyond the threshold, especially in humid environments. We recommend storing the material under inert gas and using Karl Fischer titration to verify moisture content before each campaign. For bulk procurement, our 5-bromo-7-azaindole with high assay and low impurities is packaged under nitrogen in sealed drums to maintain moisture below 0.1% upon delivery. This proactive control ensures consistent coupling efficiency and minimizes the need for boronic acid excess, directly impacting cost-efficiency in large-scale PARP inhibitor manufacturing.
Particle Size Distribution and Slurry Reactivity of 5-Bromo-7-azaindole in High-Viscosity Toluene/Ethanol Mixtures
When scaling up PARP inhibitor synthesis, the physical form of 5-bromo-7-azaindole becomes a non-trivial parameter. In high-viscosity solvent mixtures like toluene/ethanol, the dissolution rate and slurry reactivity are heavily influenced by particle size distribution (PSD). A fine powder may appear ideal for rapid dissolution, but it often leads to agglomeration and poor mixing in viscous media, causing hot spots and incomplete conversion. Conversely, large crystals dissolve too slowly, extending reaction times. Our process engineers have observed that a controlled PSD with a D90 of 100–200 µm provides optimal slurry behavior, ensuring uniform suspension and reproducible kinetics. This is particularly relevant when using 5-bromo-7-azaindole as a pharmaceutical intermediate in multi-step syntheses where intermediate isolation is avoided. For those seeking a reliable global manufacturer, we offer consistent PSD from batch to batch, a parameter often overlooked by generic suppliers. For a deeper dive into quality benchmarks, see our article on drop-in replacement for Sigma-Aldrich 692549: heavy metal limits & solvent residue.
Mitigating Catalyst Deactivation from Azaindole Nitrogen Coordination in PARP Inhibitor Synthesis
The 7-azaindole core of 5-bromo-7-azaindole contains a pyridine-like nitrogen that can coordinate to palladium catalysts, leading to deactivation and stalled reactions. This is a common pitfall in PARP inhibitor synthesis, where prolonged reaction times or increased catalyst loadings are often misattributed to poor substrate quality. In reality, the issue is inherent to the 5-bromo-1H-pyrrolo[2,3-b]pyridine scaffold. Our field experience shows that using bulky, electron-rich phosphine ligands (e.g., SPhos or XPhos) and maintaining a slightly acidic reaction environment can suppress nitrogen coordination. Additionally, pre-forming the palladium-ligand complex before substrate addition improves catalyst longevity. When troubleshooting sluggish couplings, we advise checking the ligand-to-palladium ratio and ensuring the absence of coordinating solvents like DMF. For those transitioning from lab scale to pilot plant, our technical team can provide guidance on ligand selection. This expertise is part of our commitment as a manufacturer adhering to GMP standard principles, ensuring that our 5-bromo-7-azaindole supports robust process development.
5-Bromo-7-azaindole as a Drop-in Replacement: Cost-Efficiency and Supply Chain Reliability for Vemurafenib and ABT199 Intermediates
For pharmaceutical companies manufacturing vemurafenib or ABT199 (venetoclax) intermediates, supply chain resilience is paramount. Our 5-bromo-7-azaindole is positioned as a seamless drop-in replacement for the Sigma-Aldrich 692549 product, offering identical technical parameters without the premium pricing. We achieve this through optimized synthesis routes and economies of scale, passing savings directly to bulk purchasers. The compound's role as a key intermediate in these antitumor agents demands high purity and consistent quality. Our product meets stringent specifications for assay (>99%) and single impurities (<0.5%), as verified by HPLC. Moreover, we provide comprehensive documentation, including a certificate of analysis (COA) with each shipment. For a comparison of our product with the original, refer to our article on 5-bromo-7-azaindole: substituto direto do Sigma-Aldrich 692549. By choosing our manufacturing process, you secure a dual-source strategy that mitigates risk without compromising on quality.
Field Insights: Handling Crystallization and Non-Standard Parameters of 5-Bromo-7-azaindole in Scale-Up
Beyond standard specifications, practical handling of 5-bromo-7-azaindole reveals nuances that only field experience can teach. One such non-standard parameter is its tendency to form supersaturated solutions during cooling crystallization, leading to sudden nucleation and inconsistent crystal size. We have found that seeding with micronized crystals at a controlled temperature (typically 5°C below saturation point) yields a uniform, filterable product. Another edge-case behavior is the slight discoloration (yellow to brown) upon prolonged storage above 30°C, even in the absence of moisture. This does not affect chemical purity but may raise concerns in GMP environments. Our stability studies indicate that storing at 2–8°C under nitrogen preserves the original appearance for over 12 months. For logistics, we supply the product in 210L drums or IBCs, with inner liners to prevent contamination. These insights are crucial for process chemists scaling up PARP inhibitor synthesis, where reproducibility is key. Please refer to the batch-specific COA for exact specifications, as minor variations may occur.
Frequently Asked Questions
How is 5-bromo-7-azaindole synthesized?
The synthesis of 5-bromo-7-azaindole typically starts from 7-azaindole, which is hydrogenated over Raney nickel to reduce any pyridine ring impurities. The resulting 7-azaindoline is then brominated using bromine in the presence of p-toluenesulfonic acid, followed by oxidation with manganese dioxide to rearomatize the ring. This route yields the product as a yellow crystalline solid. Alternative methods involve direct bromination of 7-azaindole with N-bromosuccinimide (NBS) under controlled conditions. Our manufacturing process is optimized for high yield and purity, with rigorous removal of residual metals and solvents.
What is the molecular weight of 5-bromo-7-azaindole?
The molecular weight of 5-bromo-7-azaindole (C7H5BrN2) is 197.03 g·mol⁻¹. This value is critical for calculating stoichiometry in coupling reactions and for preparing standard solutions in analytical methods.
What is the optimal base for Suzuki coupling with 5-bromo-7-azaindole?
For Suzuki-Miyaura couplings, weak bases like potassium carbonate (K₂CO₃) or cesium carbonate (Cs₂CO₃) are preferred. Strong bases can promote protodebromination or hydrolysis of the boronic acid. In aqueous mixtures, potassium phosphate (K₃PO₄) is often used. The choice depends on the solvent system and the boronic acid's stability. Our technical team recommends screening bases in small-scale reactions before scale-up.
How can I mitigate catalyst poisoning by the azaindole nitrogen?
Catalyst poisoning occurs when the pyridine-like nitrogen of 5-bromo-7-azaindole coordinates to palladium. To mitigate this, use bulky, electron-rich ligands such as SPhos, XPhos, or DavePhos. Pre-forming the Pd-ligand complex and avoiding coordinating solvents like DMF or NMP also helps. In some cases, adding a mild acid (e.g., acetic acid) can protonate the nitrogen and reduce its coordinating ability without affecting the bromide leaving group.
How should I handle hygroscopic degradation during multi-step workflows?
5-Bromo-7-azaindole is hygroscopic and can absorb moisture, leading to hydrolysis or reduced reactivity. Store the compound in a desiccator or under inert gas. For multi-step syntheses, use freshly opened containers and minimize exposure to air. If the compound has been exposed, dry it under vacuum at 40°C for several hours and verify moisture by Karl Fischer titration. Our packaging in nitrogen-flushed drums ensures low moisture content upon arrival.
Sourcing and Technical Support
As a dedicated manufacturer of pharmaceutical intermediates, NINGBO INNO PHARMCHEM CO.,LTD. provides 5-bromo-7-azaindole with consistent quality and reliable supply. Our product serves as a cost-effective drop-in replacement for major brands, backed by batch-specific COAs and technical support from process engineers. Whether you are optimizing a PARP inhibitor synthesis route or scaling up vemurafenib production, we offer the expertise and logistics to meet your needs. For custom synthesis requirements or to validate our drop-in replacement data, consult with our process engineers directly.